Effects of leptin on cardiovascular physiology

Journal of the American Society of Hypertension

Volumn 1, Issue 4, 2007, Pages 231-241

  Tune, Johnathan D ^a   Considine, Robert V ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerosis; cardiomyocytes; hypertension; Obesity; thrombosis

Indexed keywords

GELATINASE A; JANUS KINASE; LEPTIN; LEPTIN RECEPTOR; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; PLASMINOGEN ACTIVATOR INHIBITOR 1; STAT3 PROTEIN;

ARTERY CALCIFICATION; ATHEROSCLEROSIS; BLOOD BRAIN BARRIER; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR FUNCTION; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERLEPTINEMIA; HYPERTENSION; LATERAL HYPOTHALAMUS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SYMPATHETIC TONE; THALAMUS MIDLINE NUCLEUS; THROMBOCYTE AGGREGATION; THROMBOSIS; VASCULAR RESISTANCE; VASODILATATION; WEIGHT REDUCTION;

EID: 34447624673     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2007.04.001     Document Type: Review

References (100)

1. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432
2. nd Edition (2004), Marcel Dekker, Inc, New York, New York 275-295
3. Lee G.H., Proenca R., Montez J.M., Carroll K.M., Darvishzadeh J.G., Lee J.I., et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379 (1996) 632-635
4. Chen H., Charlat O., Tartaglia L.A., Woolf E.A., Weng X., Ellis S.J., et al. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 84 (1996) 491-495
5. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., et al. Serum immunoreactive-leptin concentrations in normal weight and obese humans. N Eng J Med 334 (1996) 292-295
6. Tartaglia L.A. The leptin receptor. J Biol Chem 272 (1997) 6093-6096
7. Munzberg H., and Myers Jr. M.G. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 8 (2005) 566-570
8. Niswender K.D., Morton G.J., Stearns W.H., Rhodes C.J., Myers Jr. M.G., and Schwartz M.W. Intracellular signaling. Key enzyme in leptin-induced anorexia. Nature 413 (2001) 794-795
9. Zhao A.Z., Huan J.N., Gupta S., Pal R., and Sahu A. A phosphatidylinositol 3-kinase phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding. Nat Neurosci 5 (2002) 727-728
10. Wang M.-Y., Zhou Y.T., Newgard C.B., and Unger R.H. A novel leptin receptor isoform in rat. FEBS Lett 392 (1996) 87-90
11. Bjorbaek C., Uotani S., da Silva B., and Flier J.S. Divergent signaling capacites of the long and short isoforms of the leptin receptor. J Biol Chem 272 (1997) 32686-32695
12. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., et al. Identification and expression cloning of the leptin receptor, OB-R. Cell 83 (1995) 1263-1271
13. Hileman S.M., Pierroz D.D., Masuzaki H., Bjorbaek C., El-Haschimi K., Banks W.A., et al. Characterizaton of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology 143 (2002) 775-783
14. Elmquist J.K., Coppari R., Balthasar N., Ichinose M., and Lowell B.B. Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis. J Comp Neurol 493 (2005) 63-71
15. Bjorbaek C., and Kahn B.B. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59 (2004) 305-331
16. Morton G.J., Cummings D.E., Baskin D.G., Barsh G.S., and Schwartz M.W. Central nervous system control of food intake and body weight. Nature 443 (2006) 289-295
17. Balthasar N., Coppari R., McMinn J., Liu S.M., Lee C.E., Tang V., et al. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 42 (2004) 983-991
18. Caro J.F., Sinha M.K., Kolaczynski J.W., Zhang P.L., and Considine R.V. Leptin: The tale of an obesity gene. Diabetes 45 (1996) 1455-1462
19. van Heek M., Compton D.S., France C.F., Tedesco R.P., Fawzi A.B., Graziano M.P., et al. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 99 (1997) 385-390
20. El-Haschimi K., Pierroz D.D., Hileman S.M., Bjorbaek C., and Flier J.S. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105 (2000) 1827-1832
21. Bjorbaek C., Elmquist J.K., Frantz J.D., Shoelson S.E., and Flier J.S. Identification Of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 191 (1998) 619-625
22. Munzberg H., Flier J.S., and Bjorbaek C. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 145 (2004) 4880-4889
23. Rahmouni K., and Haynes W.G. Leptin and the cardiovascular system. Recent Prog Horm Res 59 (2004) 225-244
24. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 189 (2006) 47-60
25. Ruige J.B., Mertens I., Considine R.V., Paelinck B.P., and van Gaal L.F. Opposite effects of insulin-like molecules and leptin in coronary heart disease of type 2 diabetes preliminary data. Int J Cardiol 111 (2006) 19-25
26. Mark A.L., Correia M.L., Rahmouni K., and Haynes W.G. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens 20 (2002) 1245-1250
27. Collins S., Kuhn C.M., Petro A.E., Swick A.G., Chrunyk B.A., and Surwit R.S. Role of leptin in fat regulation. Nature 380 (1996) 677
28. Haynes W.G., Morgan D.A., Walsh S.A., Mark A.L., and Sivitz W.I. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 100 (1997) 270-278
29. Dunbar J.C., Hu Y., and Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 46 (1997) 2040-2043
30. Aizawa-Abe M., Ogawa Y., Masuzaki H., Ebihara K., Satoh N., Iwai H., et al. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 105 (2000) 1243-1252
31. Correia M.L., Haynes W.G., Rahmouni K., Morgan D.A., Sivitz W.I., and Mark A.L. The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 51 (2002) 439-442
32. Rahmouni K., Haynes W.G., Morgan D.A., and Mark A.L. Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension 39 (2002) 486-490
33. Rahmouni K., Morgan D.A., Morgan G.M., Mark A.L., and Haynes W.G. Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 54 (2005) 2012-2018
34. Satoh N., Ogawa Y., Katsuura G., Numata Y., Masuzaki H., Yoshimasa Y., et al. Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett 249 (1998) 107-110
35. Haynes W.G., Morgan D.A., Djalali A., Sivitz W.I., and Mark A.L. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 33 (1999) 542-547
36. da Silva A.A., Kuo J.J., and Hall J.E. Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension 43 (2004) 1312-1317
37. Tallam L.S., da Silva A.A., and Hall J.E. Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension 48 (2006) 58-64
38. Seeley R.J., Yagaloff K.A., Fisher S.L., Burn P., Thiele T.E., van Dijk G., et al. Melanocortin receptors in leptin effects. Nature 390 (1997) 349
39. Marsh A.J., Fontes M.A., Killinger S., Pawlak D.B., Polson J.W., and Dampney R.A. Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus. Hypertension 42 (2003) 488-493
40. Rahmouni K., and Morgan D.A. Hypothalamic arcuate nucleus mediates the sympathetic and arterial pressure responses to leptin. Hypertension 49 (2007) 647-652
41. Winters B., Mo Z., Brooks-Asplund E., Kim S., Shoukas A., Li D., et al. Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lep(ob)) mice. J Appl Physiol 89 (2000) 2382-2390
42. Vecchione C., Maffei A., Colella S., Aretini A., Poulet R., Frati G., et al. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 51 (2002) 168-173
43. Kimura K., Tsuda K., Baba A., Kawabe T., Boh-oka S., Ibata M., et al. Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochem Biophys Res Commun 273 (2000) 745-749
44. Lembo G., Vecchione C., Fratta L., Marino G., Trimarco V., d'Amati G., et al. Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 49 (2000) 293-297
45. Fruhbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 48 (1999) 903-908
46. Gardiner S.M., Kemp P.A., March J.E., and Bennett T. Regional hemodynamic effects of recombinant murine or human leptin in conscious rats. Br J Pharmacol 130 (2000) 805-810
47. Mitchell J.L., Morgan D.A., Correia M.L., Mark A.L., Sivitz W.I., and Haynes W.G. Does leptin stimulate nitric oxide to oppose the effects of sympathetic activation?. Hypertension 38 (2001) 1081-1086
48. Jalali A., Morgan D.A., Sivitz W.I., Correia M.L., Mark A.L., and Haynes W.G. Does leptin cause functional peripheral sympatholysis?. Am J Hypertension 14 (2001) 615-618
49. Rahmouni K., Jalali A., Morgan D.A., and Haynes W.G. Lack of dilator effect of leptin in the hindlimb vascular bed of conscious rats. Eur J Pharmacol 518 (2005) 175-181
50. Nakagawa K., Higashi Y., Sasaki S., Oshima T., Matsuura H., and Chayama K. Leptin causes vasodilation in humans. Hypertension Res 25 (2002) 161-165
51. Matsuda K., Teragawa H., Fukuda Y., Nakagawa K., Higashi Y., and Chayama K. Leptin causes nitric-oxide independent coronary artery vasodilation in humans. Hypertens Res 26 (2003) 147-152
52. Sundell J., Huupponen R., Raitakari O.T., Nuutila P., and Knuuti J. High serum leptin is associated with attenuated coronary vasoreactivity. Obes Res 11 (2003) 776-782
53. Knudson J.D., Dincer U.D., Zhang C., Swafford Jr. A.N., Koshida R., Picchi A., et al. Leptin receptors are expressed in coronary arteries and hyperleptinemia causes significant coronary endothelial dysfunction. Am J Physiol Heart Circ Physiol 289 (2005) H48-H56
54. Knudson J.D., Dincer U.D., Dick G.M., Shibata H., Akahane R., Saito M., et al. Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction. Am J Physiol Heart Circ Physiol 289 (2005) H1038-H1046
55. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
56. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
57. Eiras S., Camina J.P., Diaz-Rodriguez E., Gualillo O., and Casanueva F.F. Leptin inhibits lysophosphatidic acid-induced intracellular calcium rise by a protein kinase C-dependent mechanism. J Cell Physiol 201 (2004) 214-226
58. Takekoshi K., Ishii K., Nanmoku T., Shibuya S., Kawakami Y., Isobe K., et al. Leptin stimulates catecholamine synthesis in a PKC-dependent manner in cultured porcine adrenal medullary chromaffin cells. Endocrinology 142 (2001) 4861-4871
59. Bouloumie A., Marumo T., Lafontan M., and Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 13 (1999) 1231-1238
60. Yamagishi S.I., Edelstein D., Du X.L., Kaneda Y., Guzman M., and Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 276 (2001) 25096-25100
61. Quehenberger P., Exner M., Sunder-Plassmann R., Ruzicka K., Bieglmayer C., Endler G., et al. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res 90 (2002) 711-718
62. Golden P.L., Maccagnan T.J., and Pardridge W.M. Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J Clin Invest 99 (1997) 14-18
63. Mistrik P., Moreau F., and Allen J.M. BiaCore analysis of leptin-leptin receptor interaction: evidence for 1:1 stoichiometry. Anal Biochem 327 (2004) 271-277
64. Lau D.C., Dhillon B., Yan H., Szmitko P.E., and Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 288 (2005) H2031-H2041
65. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 189 (2006) 47-60
66. O'Rourke L., Yeaman S.J., and Shepherd P.R. Insulin and leptin acutely regulate cholesterol ester metabolism in macrophages by novel signaling pathways. Diabetes 50 (2001) 955-961
67. Hergenc G., Schulte H., Assmann G., and von Eckardstein A. Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals. Atherosclerosis 45 (1999) 147-156
68. Rainwater D.L., Comuzzie A.G., Vandeberg J.L., Mahaney M.C., and Blangero J. Serum leptin levels are independently correlated with two measures of HDL. Atherosclerosis 132 (1997) 237-243
69. Kazumi T., Kawaguchi A., Hirano T., and Yoshino G. C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. Metabolism 52 (2003) 1113-1116
70. Shamsuzzaman A.S., Winnicki M., Wolk R., Svatikova A., Phillips B.G., Davison D.E., et al. Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 109 (2004) 2181-2185
71. Porreca E., Di F.C., Moretta V., Angelini A., Guglielmi M.D., Di N.M., et al. Circulating leptin is associated with oxidized LDL in post-menopausal women. Atherosclerosis 175 (2004) 139-143
72. Schafer K., Halle M., Goeschen C., Dellas C., Pynn M., Loskutoff D.J., et al. Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol 24 (2004) 112-117
73. Bodary P.F., Gu S., Shen Y., Hasty A.H., Buckler J.M., and Eitzman D.T. Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 25 (2005) e119-e122
74. Reilly M.P., Iqbal N., Schutta M., Wolfe M.L., Scally M., Localio A.R., et al. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab 89 (2004) 3872-3878
75. Iribarren C., Husson G., Go A.S., Lo J.C., Fair J.M., Rubin G.D., et al. Plasma leptin levels and coronary artery calcification in older adults. J Clin Endocrinol Metab 92 (2007) 729-732
76. Ciccone M., Vettor R., Pannacciulli N., Minenna A., Bellacicco M., Rizzon P., et al. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery. Int J Obes Relat Metab Disord 25 (2001) 805-810
77. Kang S.M., Kwon H.M., Hong B.K., Kim D., Kim I.J., Choi E.Y., et al. Expression of leptin receptor (Ob-R) in human atherosclerotic lesions: potential role in intimal neovascularization. Yonsei Med J 41 (2000) 68-75
78. Park H.Y., Kwon H.M., Lim H.J., Hong B.K., Lee J.Y., Park B.E., et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 33 (2001) 95-102
79. Hukshorn C.J., van Dielen F.M., Buurman W.A., Westerterp-Plantenga M.S., Campfield L.A., and Saris W.H. The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects. Int J Obes Relat Metab Disord 26 (2002) 504-509
80. Balasubramaniyan V., Kalaivani S.J., and Nalini N. Role of leptin on alcohol-induced oxidative stress in Swiss mice. Pharmacol Res 47 (2003) 211-216
81. Oflaz H., Ozbey N., Mantar F., Genchellac H., Mercanoglu F., Sencer E., et al. Determination of endothelial function and early atherosclerotic changes in healthy obese women. Diabetes Nutr Metab 16 (2003) 176-181
82. van den Beld A.W., Bots M.L., Janssen J.A., Pols H.A., Lamberts S.W., and Grobbee D.E. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 157 (2003) 25-31
83. Hasty A.H., Shimano H., Osuga J., Namatame I., Takahashi A., Yahagi N., et al. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem 276 (2001) 37402-37408
84. Mertens A., Verhamme P., Bielicki J.K., Phillips M.C., Quarck R., Verreth W., et al. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Circulation 107 (2003) 1640-1646
85. Nakata M., Yada T., Soejima N., and Maruyama I. Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes 48 (1999) 426-429
86. Konstantinides S., Schafer K., Koschnick S., and Loskutoff D.J. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 108 (2001) 1533-1540
87. Konstantinides S., Schafer K., Neels J.G., Dellas C., and Loskutoff D.J. Inhibition of endogenous leptin protects mice from arterial and venous thrombosis. Arterioscler Thromb Vasc Biol 24 (2004) 2196-2201
88. Corsonello A., Perticone F., Malara A., De Domenico D., Loddo S., Buemi M., et al. Leptin-dependent platelet aggregation in healthy, overweight and obese subjects. Int J Obes Relat Metab Disord 27 (2003) 566-573
89. Giandomenico G., Dellas C., Czekay R.P., Koschnick S., and Loskutoff D.J. The leptin receptor system of human platelets. J Thromb Haemost 3 (2005) 1042-1049
90. Mertens I., Considine R.V., van der Planken M., and van Gaal L.F. Hemostasis and fibrinolysis in non-diabetic overweight and obese men and women. Is there still a role for leptin?. Eur J Endocrinol 155 (2006) 477-484
91. Rajapurohitam V., Gan X.T., Kirshenbaum L.A., and Karmazyn M. The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ Res 93 (2003) 277-279
92. Xu F.P., Chen M.S., Wang Y.Z., Yi Q., Lin S.B., Chen A.F., et al. Leptin induces hypertrophy via endothelin-1 reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 110 (2004) 1269-1275
93. Tajmir P., Ceddia R.B., Li R.K., Coe I.R., and Sweeney G. Leptin increases cardiomyocyte hyperplasia via extracellular signal-regulated kinase- and phosphatidylinositol 3-kinase-dependent signaling pathways. Endocrinology 145 (2004) 1550-1555
94. Nickola M.W., Wold L.E., Colligan P.B., Wang G.J., Samson W.K., and Ren J. Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO. Hypertension 36 (2000) 501-505
95. Dong F., Zhang X., and Ren J. Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor-NADPH oxidase pathway. Hypertension 47 (2006) 222-229
96. Madani S., De Girolamo S., Munoz D.M., Li R.K., and Sweeney G. Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes. Cardiovasc Res 69 (2006) 716-725
97. Smith C.C., Mocanu M.M., Davidson S.M., Wynne A.M., Simpkin J.C., and Yellon D.M. Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Br J Pharmacol 149 (2006) 5-13
98. Unger R.H. Hyperleptinemia: protecting the heart from lipid overload. Hypertension 45 (2005) 1031-1034
99. Berg A.H., and Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96 (2005) 939-949
100. Elmquist J.K., Elias C.F., and Saper C.B. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22 (1999) 221-232